{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:16Z","timestamp":1788441376146,"version":"build-2803163510"},"reference-count":30,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82405217"],"award-info":[{"award-number":["82405217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:Beauvericin is a cyclic hexadepsipeptide derived from Bombyx batryticatus. It is known as Jiangcan in traditional Chinese medicine and has diverse pharmacological properties, including antitumor, antiviral, insecticidal, and antibacterial effects. However, its specific mechanisms against multiple myeloma (MM) are not fully understood. The aim of this study was to elucidate the mechanism of beauvericin in MM.Methods:This study utilized the mouse Sp2\/0 cell line, the human U266 cell line, and a subcutaneous tumor allograft model in C57BL\/6J mice. Flow cytometry was employed to evaluate apoptosis, and the Cell Counting Kit-8 (CCK-8) assay was used to measure cellular viability. Network pharmacology was employed for target prediction, followed by molecular docking analyses to confirm drug-target interactions. The protein expression levels of Ubiquitin-Specific Protease 9X (USP9X) and Bcl-2 were assessed by Western blotting following USP9X knockdown. Additionally, co-immunoprecipitation assays were performed to evaluate whether beauvericin modulates the Bcl-2\/USP9X interaction and affects Bcl-2 ubiquitination. The antitumor effects of beauvericin were further evaluated through in vivo experiments.Results:Network pharmacology analysis identified 82 MM-related target genes for beauvericin. These included key targets such as Caspase-3, Bcl-2, Matrix metallopeptidase 9 (MMP9), and Caspase-8, which may contribute to the anti-MM effects of beauvericin. Molecular docking revealed strong affinity and stability between beauvericin and Bcl-2. In vitro experiments confirmed that beauvericin inhibits MM cell proliferation, promotes apoptosis, and enhances Bcl-2 ubiquitination and degradation by disrupting the interaction between the deubiquitinating enzyme USP9X and Bcl-2. In vivo studies demonstrated that beauvericin treatment suppressed the growth of subcutaneous MM tumors C57BL\/6J mice.Conclusion:Beauvericin may exert its anti-MM effects by disrupting the USP9X-Bcl-2 interaction, thereby promoting Bcl-2 ubiquitination and degradation, and inducing cell apoptosis in MM cells.<\/jats:p>","DOI":"10.31083\/fbl51975","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:35:31Z","timestamp":1788438931000},"source":"Crossref","is-referenced-by-count":0,"title":["Beauvericin Exerts Antitumor Effects on Multiple Myeloma by Disrupting the USP9X-Bcl-2 Interaction to Promote Bcl-2 Degradation"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2198-1896","authenticated-orcid":true,"given":"Rui","family":"Jin","sequence":"first","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-049X","authenticated-orcid":true,"given":"Runfeng","family":"Ni","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2564-6196","authenticated-orcid":true,"given":"Ning","family":"Ding","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3702-1046","authenticated-orcid":true,"given":"Yuchen","family":"Tao","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1726-3336","authenticated-orcid":true,"given":"Shuyang","family":"Cai","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3414-586X","authenticated-orcid":true,"given":"Yirong","family":"Shi","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6037-3350","authenticated-orcid":true,"given":"Milin","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-7939","authenticated-orcid":true,"given":"Yirong","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-0277","authenticated-orcid":true,"given":"Letian","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0318-2335","authenticated-orcid":true,"given":"Jiahui","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"},{"name":"Clinical Hematology Center and Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nature Reviews. Disease Primers. 2017; 3: 17046.","DOI":"10.1038\/nrdp.2017.46"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet (London, England). 2021; 397: 410\u2013427.","DOI":"10.1016\/S0140-6736(21)00135-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Diaz-delCastillo M, Chantry AD, Lawson MA, Heegaard AM. Multiple myeloma-A painful disease of the bone marrow. Seminars in Cell & Developmental Biology. 2021; 112: 49\u201358.","DOI":"10.1016\/j.semcdb.2020.10.006"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Wang G, Qiao Y, Zhao Y, Song Y, Li M, Jin M, et al. Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K\/AKT-mediated apoptosis. Archives of Biochemistry and Biophysics. 2023; 745: 109720.","DOI":"10.1016\/j.abb.2023.109720"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kyungjin L, Bumjung K, Youngmin B, Hyejin J, Meixiang S, Minwoo K, et al. Review on the characteristics of liver-pacifying medicinal in relation to the treatment of stroke: from scientific evidence to traditional medical theory. Journal of Traditional Chinese Medicine. 2018; 38: 139\u2013150.","DOI":"10.1016\/j.jtcm.2018.01.003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lim HN, Jang JP, Shin HJ, Jang JH, Ahn JS, Jung HJ. Cytotoxic Activities and Molecular Mechanisms of the Beauvericin and Beauvericin G1 Microbial Products against Melanoma Cells. Molecules (Basel, Switzerland). 2020; 25: 1974.","DOI":"10.3390\/molecules25081974"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Hu M, Yu Z, Wang J, Fan W, Liu Y, Li J, et al. Traditional Uses, Origins, Chemistry and Pharmacology of Bombyx batryticatus: A Review. Molecules (Basel, Switzerland). 2017; 22: 1779.","DOI":"10.3390\/molecules22101779"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Heilos D, Rodr\u00edguez-Carrasco Y, Englinger B, Timelthaler G, van Schoonhoven S, Sulyok M, et al. The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study. Toxins. 2017; 9: 258.","DOI":"10.3390\/toxins9090258"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Lin HI, Lee YJ, Chen BF, Tsai MC, Lu JL, Chou CJ, et al. Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Letters. 2005; 230: 248\u2013259.","DOI":"10.1016\/j.canlet.2004.12.044"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Yahagi H, Yahagi T, Furukawa M, Matsuzaki K. Antiproliferative and Antimigration Activities of Beauvericin Isolated from Isaria sp. on Pancreatic Cancer Cells. Molecules (Basel, Switzerland). 2020; 25: 4586.","DOI":"10.3390\/molecules25194586"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"W\u00e4tjen W, Debbab A, Hohlfeld A, Chovolou Y, Proksch P. The mycotoxin beauvericin induces apoptotic cell death in H4IIE hepatoma cells accompanied by an inhibition of NF-\u03baB-activity and modulation of MAP-kinases. Toxicology Letters. 2014; 231: 9\u201316.","DOI":"10.1016\/j.toxlet.2014.08.021"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Hua Y, Tan X, Zhang J, Xu N, Chen R, Zhou S, et al. Deciphering the pharmacological mechanism of Radix astragali for allergic rhinitis through network pharmacology and experimental validation. Scientific Reports. 2024; 14: 29873.","DOI":"10.1038\/s41598-024-80101-1"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Bakhsh HT, Abu-Baih DH, Abu-Baih RH, Saber EA, Altemani FH, Algehainy NA, et al. Unveiling Lobophytum sp. the neuroprotective potential of Parkinson's disease through multifaceted mechanisms, supported by metabolomic analysis and network pharmacology. Scientific Reports. 2024; 14: 21810.","DOI":"10.1038\/s41598-024-66781-9"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang A, Chen Y, Qi D, Peng C, Liang Z, et al. Mechanism of Brucea javanica against multiple myeloma via TNF-NF-\u03baB signaling. Scientific Reports. 2025; 15: 24311.","DOI":"10.1038\/s41598-025-10271-z"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zeng J, Luo Q, Wang X, Xie W, Dong S, Fu H. Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma. Translational Cancer Research. 2023; 12: 1006\u20131020.","DOI":"10.21037\/tcr-23-456"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nature Reviews. Molecular Cell Biology. 2014; 15: 49\u201363.","DOI":"10.1038\/nrm3722"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Touzeau C, Maciag P, Amiot M, Moreau P. Targeting Bcl-2 for the treatment of multiple myeloma. Leukemia. 2018; 32: 1899\u20131907.","DOI":"10.1038\/s41375-018-0223-9"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Lernoux M, Schnekenburger M, Dicato M, Diederich M. Susceptibility of multiple myeloma to B-cell lymphoma 2 family inhibitors. Biochemical Pharmacology. 2021; 188: 114526.","DOI":"10.1016\/j.bcp.2021.114526"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews. Molecular Cell Biology. 2008; 9: 47\u201359.","DOI":"10.1038\/nrm2308"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Yamaguchi R, Lartigue L, Perkins G. Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy. Pharmacology & Therapeutics. 2019; 195: 13\u201320.","DOI":"10.1016\/j.pharmthera.2018.10.009"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Vaxman I, Sidiqi MH, Gertz M. Venetoclax for the treatment of multiple myeloma. Expert Review of Hematology. 2018; 11: 915\u2013920.","DOI":"10.1080\/17474086.2018.1548931"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature. 2010; 463: 103\u2013107.","DOI":"10.1038\/nature08646"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ye G, Jiao Y, Deng L, Cheng M, Wang S, Zhang J, et al. Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway. International Journal of Biological Sciences. 2023; 19: 4376\u20134392.","DOI":"10.7150\/ijbs.86214"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Jeong DH, Jung DW, Kim JW, Lee HS. Beauvericin, produced by Fusarium oxysporum inhibits bisphenol A-induced proliferation of human breast cancer cell line by regulating ER\u03b1\/p38 pathway. The Journal of Steroid Biochemistry and Molecular Biology. 2024; 239: 106483.","DOI":"10.1016\/j.jsbmb.2024.106483"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Juan-Garc\u00eda A, Ilie AM, Juan C, Mart\u00ednez L. Evaluating the combined and individual cytotoxic effect of beauvericin, enniatin B and ochratoxin a on breast cancer cells, leukemia cells, and fresh peripheral blood mononuclear cells. Toxicology in Vitro. 2024; 99: 105890.","DOI":"10.1016\/j.tiv.2024.105890"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nature Reviews. Clinical Oncology. 2020; 17: 395\u2013417.","DOI":"10.1038\/s41571-020-0341-y"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Fonseca R, Zhu YX, Bruins LA, Ahmann J, de Bonolo Campos C, Braggio E, et al. Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention. Blood Cancer Journal. 2025; 15: 10.","DOI":"10.1038\/s41408-025-01215-x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Silbermann R, Roodman GD. Myeloma bone disease: Pathophysiology and management. Journal of Bone Oncology. 2013; 2: 59\u201369.","DOI":"10.1016\/j.jbo.2013.04.001"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood. 2002; 99: 2162\u20132171.","DOI":"10.1182\/blood.v99.6.2162"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lee C, Oh JI, Park J, Choi JH, Bae EK, Lee HJ, et al. TNF \u03b1 mediated IL-6 secretion is regulated by JAK\/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells. BioMed Research International. 2013; 2013: 580135.","DOI":"10.1155\/2013\/580135"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL51975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:36:07Z","timestamp":1788438967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL51975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02216-1"],"URL":"https:\/\/doi.org\/10.31083\/fbl51975","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"51975"}}